Torres, T., & Blauvelt, A. (2026). High-Dose, Extended Half-Life IL-23 Inhibitors: The Next Big Step in Psoriasis Care? Dermatology & Therapy, 16(4), 1841. https://doi.org/10.1007/s13555-026-01707-z
Chicago Style (17th ed.) CitationTorres, Tiago, and Andrew Blauvelt. "High-Dose, Extended Half-Life IL-23 Inhibitors: The Next Big Step in Psoriasis Care?" Dermatology & Therapy 16, no. 4 (2026): 1841. https://doi.org/10.1007/s13555-026-01707-z.
MLA (9th ed.) CitationTorres, Tiago, and Andrew Blauvelt. "High-Dose, Extended Half-Life IL-23 Inhibitors: The Next Big Step in Psoriasis Care?" Dermatology & Therapy, vol. 16, no. 4, 2026, p. 1841, https://doi.org/10.1007/s13555-026-01707-z.
Warning: These citations may not always be 100% accurate.